OCBCO
HAE icon

Oversea-Chinese Banking Corp (OCBC)’s Haemonetics HAE Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,817
Closed -$325K – 396
2023
Q2 		$325K Buy
+3,817
New +$323K 0.02% 267

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s HAE Position: Q3 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Haemonetics (HAE) in Q3 2023, closing a stake of 3,817 shares — an estimated $325K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in HAE in Q2 2023 and held it in 1 quarter. The position peaked at $325K in Q2 2023. 296 funds tracked by Wall St. Rank hold HAE as of Q3 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Haemonetics position as of Q3 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 3,817 Haemonetics shares in Q3 2023, an estimated $325K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Haemonetics in Q2 2023 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s Haemonetics position peaked at $325K in Q2 2023.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q3 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q3 2023, filed 3 Nov 2023.